Overactive bladder — urgency, frequency, and the full treatment ladder.

What counts as overactive bladder

OAB is defined by symptoms, not by a specific test. The hallmark is urgency — a sudden, strong need to urinate that's hard to defer. Usually accompanied by:

• Frequency — going more than 8 times per day
• Nocturia — waking up more than once per night to urinate
• Urge incontinence (in some) — leaking before you reach the bathroom

OAB can affect anyone but is especially common in older adults and in women after childbirth or menopause. It's not a normal part of aging that must be tolerated.

Evaluation

The workup for OAB is usually straightforward:

• Urinalysis to rule out infection or blood in the urine.
• Post-void residual ultrasound to confirm the bladder is emptying.
• Bladder diary — a 3-day record of fluids in, urine out, and urgency episodes. This single step often reveals patterns that change treatment.
• Physical exam including pelvic exam in women.
• For men, PSA and prostate exam to rule out BPH as a contributor.

The treatment ladder — step by step

Step 1: Behavioral and lifestyle changes

Almost nobody wants to start with behavior. Almost nobody expects it to work. It often does.

• Fluid management. Limit fluids in the 2–3 hours before bed. Total daily fluid intake should be about 6–8 cups, not 12.
• Cut bladder irritants. Caffeine, alcohol, carbonated drinks, and artificial sweeteners are the worst offenders. Try eliminating them for 2 weeks and see what changes.
• Scheduled voiding. Urinate on a schedule (every 2–3 hours) rather than only when you feel urgency. Over time, this re-trains the bladder.
• Pelvic floor exercises. Strengthening the pelvic floor muscles improves urgency control. Physical therapy with a pelvic floor specialist accelerates results.
• Weight loss. Even modest weight reduction improves urinary symptoms in most patients.

Step 2: Medications

Two main drug classes, each with a different mechanism:

• Anticholinergics — oxybutynin (Ditropan), tolterodine (Detrol), solifenacin (Vesicare), fesoterodine (Toviaz), trospium (Sanctura). Block the signal that makes the bladder contract. Effective for most patients. Common side effects: dry mouth, constipation, sometimes cognitive fog (especially in older adults).
• Beta-3 agonists — mirabegron (Myrbetriq), vibegron (Gemtesa). Relax the bladder muscle through a different pathway. Fewer cognitive and dry-mouth side effects. Can slightly raise blood pressure.

Medications usually take 4–8 weeks to reach full effect. If the first one doesn't help, we try a different class. Many patients benefit from combining the two classes.

Step 3: Advanced therapies

For patients who don't improve adequately on behavioral changes + medications, there are three highly effective next steps:

Botox (onabotulinumtoxinA) for the bladder

Botox is injected into the bladder wall during a brief in-office cystoscopy. It quiets the overactive bladder muscle for 6–12 months, after which the injection is repeated. ~70% of patients see substantial improvement. The main trade-off is that about 5–10% of patients need to do intermittent self-catheterization temporarily while the bladder recovers full emptying.

Sacral neuromodulation (Axonics)

A small pacemaker-like device is implanted under the skin that sends gentle electrical signals to the nerves controlling the bladder. It "resets" the communication between bladder and brain. Done in two stages: a test lead first to see if it works for you, then a permanent implant if it does. ~70–85% of patients see major improvement, and the newest Axonics devices are rechargeable and MRI-compatible.

Percutaneous tibial nerve stimulation (PTNS)

A small needle electrode near the ankle delivers stimulation to a nerve that communicates with the bladder. Weekly 30-minute sessions for 12 weeks. Less invasive than Axonics but less durable — requires ongoing maintenance sessions.

What to expect from treatment

Most patients significantly improve, but complete symptom elimination is uncommon. A realistic goal is reducing episodes by 50–70% and getting back to normal daily activities without constantly planning around bathroom access.

The key is to start somewhere and iterate. If behavioral changes aren't enough, we add medication. If medication isn't enough, we move to Botox or Axonics. Each step is reversible and builds on the last.